NPPES file of Aug 9, 2026

Shajla Ajas, MD

Hematology & Oncology Physician · Pennington, NJ

Shajla Ajas, MD is a hematology & oncology physician with a practice address in Pennington, New Jersey, and NPI 1598241747, issued on Jul 11, 2018. Check the license (New Jersey 25MA11152700, as entered in NPPES) on the New Jersey State Board of Medical Examiners; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1598241747
Name
Shajla Ajas
Credential
MD
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License number
25MA11152700 NJ
Self-reported in NPPES; status is on the state search
Practice location
2 Capital Way Ste 220, Pennington, NJ 08534
Phone
(609) 303-0747
Enumerated
Jul 11, 2018
Record last updated
Aug 5, 2025
Medicare enrollment
Enrolled (PECOS I20220602002233); accepts Medicare assignment
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 2 Capital Way Ste 220

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Rakesh Biswas, MDHematology & Oncology Physician1679003487
  2. Pamela Crilley, DOHematology & Oncology Physician1538116041
  3. Peter Graham, MDMedical Oncology Physician1841385226
  4. Jennifer Hong, MDHematology & Oncology Physician1619400280
  5. Dongyoun Lee, M.D.Medical Oncology Physician1073919312
  6. Hongyan Liang, MDHematology & Oncology Physician1194931568

Verify Shajla Ajas in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersNew Jersey State Board of Medical Examiners
    Search for license 25MA11152700
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the New Jersey license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

91% fewer Medicare Part D claims than the average hematology & oncology physician in 2024

83 Medicare Part D claims for 20 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D.

  1. Shajla Ajas83
  2. Specialty average877

Most prescribed

  1. Amlodipine Besylate13 claims
  2. Anastrozole13 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $811.21

23 payments; by number, the most common kind was food and beverage; the largest payer was Janssen Biotech, Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Shajla Ajas$811.21
  2. Specialty average$7,481.41

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Capital Health Medical GroupPennington, NJ

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

10 hematology & oncology physician records list a practice address in Pennington

They are 10 of the 739 NPPES records with a practice address in Pennington, and 399 hematology & oncology physician records in New Jersey.

Other hematology & oncology physician records in New Jersey

  1. May Abdo-Matkiwsky, D.O.Sparta, NJ1306887708
  2. Stephen Abo, D.O.Newark, NJ1891717708
  3. Ahmed Abou Hussein, M.D.Camden, NJ1841502275
  4. Kenneth Adler, M.D,Morristown, NJ1922096916
  5. Richards Afonja, MDClifton, NJ1255300141
  6. Manmeet Ahluwalia, DOHowell, NJ1053706168
  7. Kaleem Ahmad, M.D.Marmora, NJ1629065982
  8. Rajasree Ajay, M.D.Galloway, NJ1942257787
  9. Joel Alcid, M.D.Rutherford, NJ1114248002
  10. Alpesh Amin, M.D.Orange, NJ1972540797

Common questions

What is Shajla Ajas, MD's NPI number?

Shajla Ajas, MD's National Provider Identifier (NPI) is 1598241747, issued on Jul 11, 2018. An NPI identifies a provider in billing; it is not a license.

Where is Shajla Ajas, MD located?

The NPPES record lists a practice address at 2 Capital Way Ste 220, Pennington, NJ, 08534. Phone: (609) 303-0747. Providers update this record themselves, so call before visiting.

How can I verify Shajla Ajas, MD's license?

NPPES lists New Jersey license number 25MA11152700, as entered by the provider. Search the New Jersey State Board of Medical Examiners at https://newjersey.mylicense.com/verification/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Shajla Ajas, MD prescribe under Medicare Part D?

In 2024, Shajla Ajas, MD had 83 Medicare Part D claims for 20 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.